Introduction to homotoxicology

Homotoxicology, the theory of disease developed by Dr. Hans-Heinrich Reckeweg (1905-1985), understands illness as the human body’s defense against toxic substances (homotoxins) that threaten to overwhelm the intercellular matrix. According to this therapeutic model, the type and severity of an illness are determined by the duration and intensity of toxin loading in relationship to the body’s inherent capacity for detoxification. «Clogging» of the matrix obstructs the movement of nutrients from blood vessels into cells, disrupting the body’s steady state and hindering important biological processes. The resulting disturbances, which eventually manifest as illness, are the body’s attempt to restore a state of biochemical balance. For Reckeweg, restoring this balance was the ultimate goal of all medical treatment.

The link between conventional medicine and homeopathy
Antihomotoxic medications retain the low rate of side effects of homeopathic remedies. As antihomotoxic combination medications can be treated like allopathic medications, they can be prescribed for specific indications regardless of constitutional differences among patients. They make homeopathy accessible to many more patients and physicians who are not trained as homeopaths. These two advantages have helped establish homotoxicology as a bridge between conventional (allopathic) medicine and homeopathy. The most recent results of clinical trials of Heel products suggest that the term «modern homeopathy» is indeed an appropriate synonym for homotoxicology.

הציטוט מתוך האתר של חברת Heel


IT ALL BEGAN WITH "LABORATORIUM EUPHA"

Although now extensively renowned, the Dr. Reckeweg Company traces its origins back to humble beginnings, as a family operated business. At the turn of the century, Dr. Heinrich Reckeweg (1877-1944) - a native of Herford, Westphalia, Germany - founded "Laboratorium EUPHA". Using his experience and knowledge of homeopathic medicine, the first complex agents, based on Hahnemann's principle of similars, were developed. In 1947, Dr. Alfred Reckeweg, homeopath, and his brother, Dr. Klaus-Gnther Reckeweg, both direct descendants of Dr. Heinrich Reckeweg, re-established the company under a new name: The Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH.
The rebirth of the company brought with it a mandate for the preservation of internationally accepted standards of high quality. Presently directed by Dr. Klaus-Gnther's son, Michael Reckeweg, the company scrupulously abides by the heritage and praxis of Dr. Heinrich Reckeweg. Tradition and custom are maintained despite state-of-the-art facilities, manufacturing techniques and methods of organizational management. As the founder of "Laboratorium EUPHA", Dr. Heinrich Reckeweg was personally committed to the manufacturing of safe and effective remedies.
It is to the strict adherence to this philosophy that we owe the international success of the Dr. Reckeweg homeopathic specialties.

ציטוט מתוך האתר www.reckeweg.com